Novo Nordisk

A fire broke out on Tuesday at a Novo Nordisk building in Denmark, the pharmaceuticals giant told Reuters.

The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.

In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients' appetite and helps them to lose about 15 per cent of their body weight.

The world's largest insulin maker, Novo Nordisk, is cutting 1,000 jobs as a part of a plan to reduce costs as it faces a challenging environment in 2017, especially in the large U.S. market, the company said.

In New Orleans Monday, a major medical organization attempted a feat perhaps as hard as treating the disease doctors were there to discuss. They asked a packed convention hall of attendees not to tweet the confidential, market-moving data they had flown in to see.

In addition, Novo Nordisk has also initiated the Changing Diabetes in Children, a programme designed to improve access to diabetes care for children with type 1 diabetes.

China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and ageing population.

Harvard Business Review just released its annual ranking of the world's best-performing CEOs on Monday, and this year's winner is a leader in health care who remains laser-focused on diabetes treatments, doesn't fly in private jets, and will be relatively unknown to many readers in the United States.

Sun Pharmaceutical Industries rose 2.4 per cent after the U.S. Supreme Court allowed the Indian drug maker to sue a brand name rival

Sun Pharma's US subsidiary Caraco can sue Denmark's Novo Nordisk to narrow description of a patented drug.

Leading healthcare company Novo Nordisk on Monday announced the launch of its new global blockbuster injectible offering Victoza, a drug for treatment of diabetes, in India. Part of the liraglutide family of drugs, Victoza, which also helps to reduce obesity, is targeted at diabetic population who produce insufficient insulin, more commonly...

A fire broke out on Tuesday at a Novo Nordisk building in Denmark, the pharmaceuticals giant told Reuters.

The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.

In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients' appetite and helps them to lose about 15 per cent of their body weight.

The world's largest insulin maker, Novo Nordisk, is cutting 1,000 jobs as a part of a plan to reduce costs as it faces a challenging environment in 2017, especially in the large U.S. market, the company said.

In New Orleans Monday, a major medical organization attempted a feat perhaps as hard as treating the disease doctors were there to discuss. They asked a packed convention hall of attendees not to tweet the confidential, market-moving data they had flown in to see.

In addition, Novo Nordisk has also initiated the Changing Diabetes in Children, a programme designed to improve access to diabetes care for children with type 1 diabetes.

China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and ageing population.

Harvard Business Review just released its annual ranking of the world's best-performing CEOs on Monday, and this year's winner is a leader in health care who remains laser-focused on diabetes treatments, doesn't fly in private jets, and will be relatively unknown to many readers in the United States.

Sun Pharmaceutical Industries rose 2.4 per cent after the U.S. Supreme Court allowed the Indian drug maker to sue a brand name rival

Sun Pharma's US subsidiary Caraco can sue Denmark's Novo Nordisk to narrow description of a patented drug.

Leading healthcare company Novo Nordisk on Monday announced the launch of its new global blockbuster injectible offering Victoza, a drug for treatment of diabetes, in India. Part of the liraglutide family of drugs, Victoza, which also helps to reduce obesity, is targeted at diabetic population who produce insufficient insulin, more commonly...